Dexcom, Inc. is a medical device company. The Company is primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems for use by people with diabetes and by healthcare providers. Its products include Dexcom G6 and Dexcom Share. The G6 is a CGM system that can be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin dosing systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. Its Dexcom Share remote monitoring system, offered for use with its Dexcom system, uses an app on the patient’s iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients, who can remotely monitor a patient’s glucose information and receive alert notifications.
52 Week high
52 Week low
InvestorPlace • 1 day ago • DXCMGlucose Game-Changers: 3 Diabetes Stocks to Grab on the Downturn
Barrons • 2 days ago • DXCMWeight-Loss-Drug Stock Sting May Be Easing for Device Makers
Business Wire • 3 days ago • DXCMDexcom Solidifies Global Leadership in Continuous Glucose Monitoring With New Clinical Data Presented at EASD
Business Wire • 6 days ago • DXCMDexcom Schedules Third Quarter 2023 Earnings Release and Conference Call for October 26, 2023 at 4:30 p.m. Eastern Time.
Zacks Investment Research • 7 days ago • DXCMDexCom (DXCM) Partners With RxFood for Automated Dietary Monitoring
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.